# The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment

> **NCT06814288** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Universitas Padjadjaran** · enrollment: 20 (estimated)

## Conditions studied

- Keloid Scars

## Interventions

- **DRUG:** Botulinum toxin A
- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT06814288
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06814288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06814288, "The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06814288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*